Trivant Custom Portfolio Group, LLC Moderna, Inc. Transaction History
Trivant Custom Portfolio Group, LLC
- $171 Billion
- Q4 2024
A detailed history of Trivant Custom Portfolio Group, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 20 shares of MRNA stock, worth $847. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 120
83.33%
Holding current value
$847
Previous $8.02 Million
89.63%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MRNA
# of Institutions
933Shares Held
240MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.8 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.71 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.08 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$714 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$306 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $16.6B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...